Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)

NCT05508074

Conditions
ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
Locations
  • Hôpital Neurologique Pierre Wertheimer Bron, France
  • APHM Hôpital La Timone Adultes SCE Maladies Neuromusculaires / SLA Marseille, France
  • CHU de Nantes - Hôpital Laennec Nantes, France
  • CHU de Toulouse - Hôpital Pierre-Paul Riquet Toulouse, France
View Trial Details
Completed

Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis

NCT04632225

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • St. Joseph's Hospital and Medical Center, Barrows Neurological Institute Phoenix, Arizona, United States
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University Department of Neurology Baltimore, Maryland, United States
  • Austin Neuromuscular Center Austin, Texas, United States
View Trial Details

Related conditions